Did you find yourself breathing a sigh of relief at some point in the past year, thinking all the hullabaloo over the theories and practices of risk-based monitoring (RBM) and risk management in the clinical research enterprise had finally died down? Think again. Signs of ongoing concerns over the proper roles and execution of the […]
Gatherings of representatives from clinical trial sponsors and sites aren’t always inspiring or uplifting, but don’t tell that to Victoria DiBiaso, from Clinical Sciences & Operations in Sanofi’s R&D organization. “We had a global meeting [in early June] with approximately 30 sites from around the world that are part of our site partnerships program,” recounts […]
Scientists with the Dominantly Inherited Alzheimer Network (DIAN) at the Washington University in St. Louis School of Medicine are undertaking five years of studies of a rare form of early-onset Alzheimer’s disease using a “bring your own device” (BYOD) study model. The DIAN research incorporates an observational study, clinical drug trials, a research registry, and […]
It doesn’t take a rocket scientist to see the value of certification, according to clinical trial thought leader Christina Brennan, MD, MBA, CCRC, vice president of clinical research at Northwell Health in New York. Brennan sees the positive impact of certification every day on the job at Northwell, where she has overseen clinical research support […]
Clinical trial practitioners and new technologies continue their tentative dance toward mutual acceptance, as a new survey shows usage on the rise but at a sometimes-disappointing pace. “We’re seeing that the industry is making progress in adopting more purpose-filled clinical applications, but there’s still a heavy reliance on manual processes and legacy systems,” says Jim […]
